Investing Profile

Wende Hutton

VCInvestor

General Partner at Canaan Partners

canaan.com/team/wende-huttonMenlo Park, California

Your Intro Paths to Wende Hutton

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Wende Hutton on

Current Investing Position

Canaan Partners General Partner

Investment Range

$250K - $20.0M

Sweet Spot

$10.0M

Investments On Record

Current Fund Size

$800M

Wende Hutton is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)BioTech (Series A)Health IT (Series A)Pharmaceuticals (Series A)Diverse Investors Female Investors Health & Hospital Services (Series A)San Francisco Bay Area Health IT (Seed)Health & Hospital Services (Seed)

Wende Hutton's Investments On Record (20)

Company	StageDateRound Size	Total Raised
Glooko	Series FOct 2024$100M Series CJun 2017$35M Series CSep 2016$8M Series BMar 2015$17M	$170M
Co-investors: Chamath Palihapitiya (Social Capital), Ted Maidenberg (Tribe Capital), Anand Rajaraman (rocketship.vc), David Carrico (Jlabs), Venky Harinarayan (rocketship.vc), Bill Campbell, Sundeep Madra
Qlaris Bio	Series BApr 2024$24M	$24M
OncoResponse	Series DMay 2023$14M Series CMar 2021$41M Series BSep 2018$40M Series AMay 2016$13M	$110M
Co-investors: John McKearn (RiverVest)
Antiva Biosciences	Series EApr 2023$53M Series DNov 2021$31M Series CJul 2018$15M Series CMar 2017$22M Series BAug 2015$16M	$140M
Co-investors: Jenny Yip (Adjuvant Capital)
MoCaFi	Series AFeb 2021$12M	$40M
Co-investors: Dan Rosen (Commerce Ventures), Karen Kerr (GE Ventures), Thompson Hutton (Thompson Hutton, LLC), Lorine Pendleton (125 Ventures)
Hyalex Orthopaedics	Series AMar 2019$17M Series AMay 2017$16M	$33M
Co-investors: V.Kadir Kadhiresan (Johnson & Johnson Innovation), Bill Harrington (Osage University Partners), Renee Compton Ryan (Johnson & Johnson Innovation)
ReVision Optics	Series UnknownNov 2016$32M Series EJul 2013$55M Series EApr 2013$15M Series DJul 2010$35M Series CJun 2006$3M Series COct 2005$12M Series CDec 2004$5M	$180M
Co-investors: Bruce Cleveland (Wildcat Ventures), Gil Kliman (InterWest), Brian Dovey (Domain Associates), Renee Compton Ryan (Johnson & Johnson Innovation), Reza Zadno (InterWest)
Chrono Therapeutics	Series BSep 2016$48M Series AJun 2014$32M	$80M
Co-investors: James Young (5am Ventures), Liz Rockett (Kaiser Permanente Ventures)